HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Losartan titration versus diuretic combination in type 2 diabetic patients.

AbstractMETHODS:
We compared the effects of Losartan dose titration to 100 mg versus the addition of 12.5 mg of hydrochlorothiazide, in 90 type 2 diabetic patients with microalbuminuria and blood pressure > 130/85 mmHg, receiving losartan 50 mg as initial treatment during 4 weeks.
RESULTS:
With the first dose of losartan, systolic (SBP) and diastolic blood pressure (DBP) decreased from 154.5 (152.1-157.5) to 144.4 (141.3-147.5) mmHg (P < 0.001) and from 91.1 (89.4-92.8) to 84.6 (82.8-86.4) mmHg (P < 0.001), with 20 patients attaining the expected goal blood pressure (< 130/85 mmHg); albuminuria decreased from 109.8 (90.5-133.3) to 83.5 (63.6-109.5) mg per 24 h (P = 0.006). Patients not attaining the target blood pressure were randomly allocated to titration or to the combination arm. After an additional 4 weeks, patients titrated exhibited a fall in SBP and DBP from 157.1 (152.7-161.5) to 142.1 (136.4-147.8) mmHg (P < 0.001) and from 92.4 (89.5-95.3) to 83.6 (81.1-86.1) mmHg (P < 0.001); albuminuria decreased from 136.3 (97.8-189.9) to 99.7 (69.3-143.4) mg per 24 h (P = 0.002). In the combination arm, there were similar reductions in SBP and DBP from 155.3 (151.5-159.1) to 139.1 (132.1-146.1) mmHg (P < 0.001) and from 92.1 (89.3-94.9) to 80.9 (77.4-84.4) mmHg (P < 0.001); while albuminuria fell from 107.7 (82.2-141.0) to 64.2 (45.9-89.9) mg per 24 h (P = 0.001).
CONCLUSIONS:
Losartan 50 mg was effective in reducing blood pressure and albuminuria in type 2 diabetic patients. When the blood pressure target was not reached, the two strategies tested seem to contribute similarly to further reductions in blood pressure and albuminuria.
AuthorsPedro Luis de Pablos-Velasco, Fernando Pazos Toral, Juan E Esmatjes, Francisco Fernandez-Vega, Martín Lopez Lopez de la Torre, Antonio Pozuelo, Luis M Ruilope
JournalJournal of hypertension (J Hypertens) Vol. 20 Issue 4 Pg. 715-9 (Apr 2002) ISSN: 0263-6352 [Print] England
PMID11910308 (Publication Type: Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial)
Chemical References
  • Antihypertensive Agents
  • Diuretics
  • Sodium Chloride Symporter Inhibitors
  • Hydrochlorothiazide
  • Losartan
Topics
  • Aged
  • Albuminuria (drug therapy, etiology)
  • Antihypertensive Agents (administration & dosage)
  • Blood Pressure (drug effects)
  • Cardiovascular Diseases (prevention & control)
  • Diabetes Mellitus, Type 2 (complications, drug therapy, physiopathology)
  • Diabetic Angiopathies (prevention & control)
  • Diabetic Nephropathies (prevention & control)
  • Diuretics
  • Drug Therapy, Combination
  • Female
  • Humans
  • Hydrochlorothiazide (administration & dosage)
  • Hypertension (drug therapy, etiology, physiopathology)
  • Losartan (administration & dosage)
  • Male
  • Middle Aged
  • Sodium Chloride Symporter Inhibitors (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: